BioMed Research International

Volume 2013 (2013), Article ID 263509, 10 pages

http://dx.doi.org/10.1155/2013/263509

Research Article

Antioxidant Capacity and Antimutagenic Potential of Murraya koenigii

Maryam Zahin,1,2 Farrukh Aqil,1,2 Fohad Mabood Husain,¹ and Iqbal Ahmad¹

¹Department of Agricultural Microbiology, Aligarh Muslim University, Aligarh 202 002, India

²James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA

Received 11 April 2013; Accepted 2 June 2013

Academic Editor: Vincent Ribrag

Copyright © 2013 Maryam Zahin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

It is well known that the intake of antioxidants with increased consumption of fruits and vegetables and medicinal herbs contributes towards reduced risk of certain diseases including cancers. This study aims to evaluate the broad-spectrum antioxidant and antimutagenic activities as well as to elucidate phytochemical profile of an Indian medicinal plant Murraya koenigii (curry) leaves. Leaves of the plant were successively fractionated in various organic solvents. Benzene fraction demonstrated the highest phenolic content followed by petroleum ether. The benzene fraction showed maximum antioxidant activity in all tested assays, namely, phosphomolybdenum, 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical, ferric reducing antioxidant power (FRAP) and cupric reducing antioxidant capacity (CUPRAC) assays. Based on the promising broad-spectrum antioxidant activity, benzene fraction was further evaluated for antimutagenic activity and showed a dose-dependent antimutagenic response in Ames Salmonella mutagenicity assay. It inhibited 72–86% mutagenicity induced by sodium azide, methyl methanesulfonate, benzo(a)pyrene, and 2-aminoflourene at the maximum tested concentration (100 µg/mL) in Salmonella typhimurium tester strains. At least 21 compounds were detected by GC/MS. The findings clearly demonstrated that phenolic-rich benzene fraction has promising broad-spectrum antioxidant and antimutagenic property and needs further evaluation to exploit its therapeutic potential.

1. Introduction

During the past decades, it became obvious that most degenerative diseases are associated with reactive oxygen species (ROS) such as superoxide anion radicals, hydroxyl radicals, and hydrogen peroxide [1]. Under stress conditions, our bodies produce more ROS which creates homeostatic imbalance and generates oxidative stress and causes cell death and tissue injury [2]. There are endogenous as well as exogenous systems to protect cells from damage in animals. However, in many conditions, the endogenous antioxidants are depleted and therefore exogenous supply of antioxidants becomes essential.

Antioxidants play an important role in biological systems [3] by suppressing the formation of active oxygen species by reducing hydroperoxides (ROO•) and H₂O₂ and scavenging free radicals among others. Antioxidants are classified as natural/synthetic exogenous or endogenous compounds that can play a role in the removal of free radicals, scavenging ROS or their precursors, inhibiting formation of ROS and binding metal ions needed for catalysis of ROS generation, and so forth [1]. Plant-derived natural products could function as antioxidant especially singlet and triplet oxygen quenchers, peroxide decomposers, enzyme inhibitors, or synergists [4, 5].

Human exposure to genotoxic substances present in environment and the food is inevitable. Study of mutagenesis has assumed importance due to the fact that mutations play an important role in carcinogenesis [6]. Consequently, from cancer-preventing point of view, an interest has also been aroused in the presence of antimutagens in foodstuffs as well as in traditionally used medicinal plants, herbs, and spices [7]. On the other hand, mechanism of mutagenesis is complex; however, many mutagens and carcinogens may act through the generation of ROS. Therefore, the discovery and exploration of plant extracts/phytocompounds possessing both antioxidant and antimutagenic properties are of great practical and therapeutic significance. It has also been shown that the increased consumption of fruits and vegetables has generally been found protective against a variety of cancers. Thus, it is presumed that plant with high antioxidant activity could also show antimutagenic activity and counteract the effect of the mutagens and carcinogens [8, 9].

The screening of plant extracts/phytocompounds for antimutagenic activity has been performed using several mutagen assay systems in bacteria, yeast, and some plant and animal cell cultures [10]. Several authors have documented the antimutagenic activity of plant extracts associated with secondary metabolites that act as antimutagen [11–13]. But concerted efforts are needed to explore and exploit the Indian medicinal plants in mutation-related carcinogenesis.

Murraya koenigii (family: Rutaceae), commonly known as curry leaf, is a native of India, Sri Lanka, and other south Asian countries and has been used in various cuisine as natural flavouring agent [14]. In addition to its dietary use, this plant has also been used in Indian system of traditional medicine as tonic, stomachic, carminative, and for hypoglycemic properties [15]. The plant has been subjected to intensive investigation and possesses various biological activities [16].

We have previously reported that Indian medicinal plants are rich in novel compounds that possess antioxidant and antimutagenic potential [12, 17, 18]. In this paper we discuss the fraction-based antioxidant and antimutagenic properties of curry leaves as well as their active constituents, especially essential oils. The broad-spectrum antioxidant activity using various systems and its antimutagenic potential against both direct and indirect mutagens in vitro using Ames Salmonella tester strains has also been reported.

2. Material and Method

2.1. Bacterial Strains and Chemicals

The Salmonella typhimurium strains TA97a, TA98, TA100, and TA102 were kindly provided by Professor B. N. Ames, University of California, Berkeley, USA. Sodium azide (NaN₃), nicotinamide adenine dinucleotide phosphate sodium salt, D-glucose-6-phosphate disodium salt, sodium phosphate, ammonium molybdate, neocuproine, ferric chloride, L-histidine monohydrate, D-biotin and antioxidant standards (butylated hydroxy toluene (BHT), ascorbic acid, and gallic acid) were purchased from Hi-Media Lab. Ltd., Mumbai, India. Potassium ferricyanide, cupric chloride, and ammonium acetate were purchased from Qualigens Fine Chemicals, Mumbai, India. Methyl methanesulfonate (MMS) and trichloroacetic acid were purchased from Sisco-Research Laboratories Pvt. Ltd., Mumbai, India, while 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals, 2-aminofluorene (2 AF), and benzo(a)pyrene (BP) were purchased from Sigma Chemical Co., St. Louis, MO, USA. All the other reagents used to prepare buffers and media were of analytical grade.

2.2. Plant Material and Preparation of Extracts

Leaves of Murraya koenigii (L.) were collected locally from the campus of Aligarh Muslim University (AMU), Aligarh, India. The plant was further identified by a taxonomist in the Department of Botany, AMU, Aligarh, and voucher specimen (MBD-14/06) was deposited in the Department of Agricultural Microbiology, AMU, Aligarh, India. The leaves were shade-dried, ground finely and extract was prepared as described earlier [18]. Briefly, five hundred grams of dry leaf powder was soaked in 2.5 L of petroleum ether for 5 days with intermittent shaking and finally, the extract was filtered through Whatman filter paper no. 1 (Whatman Ltd., England) to make a petroleum ether fraction. The collected dried powder was successively extracted with benzene, ethyl acetate, acetone, methanol, and ethanol. The filtered fractions were concentrated to dryness under reduced pressure on rotary evaporator at 40°C and stored at 4°C for future use. The yield of the dried fractions was calculated and extracts were reconstituted in minimum amount of DMSO (≤0.1%) to perform experiments.

2.3. Antioxidant Assays

Antioxidant potential of different fractions from curry leaves was determined by DPPH free radical scavenging assay, the ferric reducing power assay (FRAP), and cupric ions (Cu²⁺) reducing ability (CUPRAC) assays as well as total antioxidant capacity was evaluated by phosphomolybdenum method.

2.3.1. Determination of Total Antioxidant Capacity by Phosphomolybdenum Method

The total antioxidant capacity of different fractions was evaluated by the method of Prieto et al. [19]. An aliquot of 0.1 mL of sample solution (containing 12.5, 25, 50, and 100 μg/mL of respective fraction) was combined with 1 mL of reagent (0.6 M sulphuric acid, 28 mM sodium phosphate and 4 mM ammonium molybdate). Methanol (0.1 mL) was used as blank in place of the sample. The tubes were capped and incubated in a boiling water bath at 95°C for 90 min, and then cooled at room temperature. The absorbance of each solution was then measured at 695 nm against a blank in a double beam UV-Vis spectrophotometer UV570455 (EC, Electronic Corporation of India Limited). For samples of unknown composition, water-soluble antioxidant capacity of the extract was expressed as equivalents of ascorbic acid (μmol/g).

2.3.2. DPPH Radical Scavenging Assay

Free radical scavenging activity of different fractions against stable DPPH was determined spectrophotometrically by the modified method of Gyamfi et al. [20] as described earlier [17]. When DPPH reacts with an antioxidant, which can donate hydrogen, it is reduced. The changes in color (from deep violet to light yellow) were measured at 517 nm on a UV-Vis spectrophotometer (Spectronic 20 D+, USA). Fifty microliters of the solvent-dried leaf fractions, yielding 12.5, 25, 50, and 100 μg/mL, respectively, in each reaction was mixed with 1 mL of 0.1 mM DPPH in methanol solution and 450 μL of 50 mM Tris-HCl buffer (pH 7.4). Methanol (50 μL) was used as a vehicle control in the experiment. After 30 min of incubation at room temperature, the reduction of the DPPH free radicals was measured spectrophotometrically. Ascorbic acid and BHT were used as controls. Percent inhibition was calculated from the following equation:

where is the absorbance of control and is the absorbance of test sample

2.3.3. FRAP Assay (Fe³⁺ Reducing Power Assay)

The ferric reducing antioxidant power (FRAP) method of Oyaizu [21] with little modification [22] was adopted to measure the reducing capacity. FRAP assay measured direct reduction of Fe³⁺(CN⁻)₆ to Fe²⁺(CN⁻)₆, resulting in formation of the Perl’s Prussian Blue complex following the addition of excess ferric ions (Fe³⁺). Concentrations of extracts (12.5–100 μg/mL) in 0.75 mL of distilled water were mixed with 1.25 mL of 0.2 M (pH 6.6) sodium phosphate buffer and 1.25 mL of 1% potassium ferricyanide [K₃Fe (CN₆)]. After 20 min of incubation at 50°C for 20 min, the reaction mixture was acidified with 1.25 mL of 10% trichloroacetic acid. Finally, 0.5 mL of 0.1% FeCl₃ was added and absorbance was measured at 700 nm. The increase in absorbance of the reaction mixture indicates greater reduction capability.

2.3.4. CUPRAC Assay

In order to determine the cupric ions (Cu²⁺) reducing ability of curry leaf extracts, the method of Apak et al. [23] was used with a little modification as described by Gülçin [24]. Briefly, 0.25 mL CuCl₂ solution (0.01 M), 0.25 mL ethanolic neocuproine solution (7.5 × 10⁻³ M), and 0.25 mL CH₃COONH₄ buffer (1 M) were added to a test tube, followed by mixing with different concentrations of extracts (12.5–100 μg/mL). The total reaction volume was adjusted to 2 mL with distilled water, and the solution was mixed well. The tubes were stoppered and kept at room temperature for 30 min, and absorbance was measured at 450 nm. Increased absorbance of the reaction mixture indicates increased reduction capability.

2.4. Antimutagenicity Assay

The Salmonella histidine point mutation assay described by Maron and Ames [25] was used to test the antimutagenic activity of the extracts as described earlier [12, 17]. In the preincubation experiment, a mixture of solvent-dried curry leaves extracts and mutagen, each having a volume of 0.1 mL of varying extract concentrations, was preincubated at 37°C for 30 min and then 0.1 mL of 1 × 10⁷ CFU/mL density of the bacterial culture was added, followed by the addition of 2.5 mL of top agar (0.5% NaCl and 0.6% agar) supplemented with 0.5 mM histidine and biotin each at 45°C.

The influence of metabolic activation of indirect acting mutagens, BP and 2-AF, was tested using 500 μL of S9 mixture (0.04 mg proteins/mL of mix). The S9 microsome fraction was prepared from the livers of rats treated with Aroclor 1254 using standard protocols [25]. The solution was vortex mixed and poured onto minimal glucose plates (40% glucose and Vogel Bonner medium). The plates were incubated at 37°C for 48 h, after which the numbers of histidine-independent revertant colonies were scored.

Survival of the tester bacterial strains was routinely monitored for each experiment. To check the toxicity of the test samples, parallel controls were run with extracts alone at all concentrations tested with mutagens. The concentrations of the test sample for investigating the antimutagenicity were 12.5, 25, 50, and 100 μg solvent-dried extract/0.1 mL/plate. These were tested against direct acting mutagens sodium azide (1.5 μg/0.1 mL/plate) and MMS (1 μg/0.1 mL/plate) in TA97a, TA98, TA100, and TA102 tester strains as well as against indirect acting mutagens BP and 2-AF. All the test samples and mutagens were dissolved in minimum volume of DMSO. In each case, no toxicity was observed and the numbers of spontaneous revertants were identical to the DMSO vehicle control. Nontoxic concentrations were categorized as those where there was a well-developed lawn, almost similar size of colonies and no statistical difference in the number of spontaneous revertants in test and control plates. Triplicate plates were set up with each concentration and the entire experiment was repeated twice that provided six replicates per treatment. Inhibition of mutagenicity was expressed as percentage decrease of reverse mutation and calculated as:

where is the number of histidine revertants induced by mutagen, is the number of histidine revertants induced by mutagen in the presence of plant extract, and is the number of revertants induced in negative control.

2.5. Total Phenolic Content of Plant Fractions

The total phenolic content of the plant fractions was determined using Folin-Ciocalteau reagent by the method in [26], as described earlier [18]. Briefly, to 0.5 mL of each sample (containing 12.5, 25, 50 and 100 μg/mL of the extract), 2.5 mL of 1/10 dilution of Folin-Ciocalteau’s reagent and 2 mL of Na₂CO₃ (7.5%, w/v) were added and incubated at 45°C for 15 min. Each experiment was performed in triplicate. The absorbance of all samples was measured at 765 nm using a UV-Vis spectrophotometer. Results are expressed as milligrams of gallic acid equivalent per gram of extract dry weight (mg GAE/g dw).

2.6. Gas Chromatography Mass Spectrometry (GC-MS)

The active fraction of the extracts was subjected to GC-MS in order to identify the active constituents. The GC was done on GCD 1800 A, Hewlett Packard, coupled with HP-1 column (30 m × 0.25 mm × 0.25 μm; Thermo Scientific, USA). Injector and detector temperatures were 250°C and 280°C, respectively. The carrier gas used was helium at 1 mL/min; initial temperature of oven was 100–250°C at the rate of 10°C/min, hold time was at 250°C for 3 min and final temperature was 250–280°C at the rate of 30°C/min and hold time at 280°C for 2 min. The solvent used for making all dilutions was methanol.

2.7. Statistical Analysis

The results are presented as the mean of three experiments with triplicate plates/dose/experiment. The data were further analyzed for statistical significance using analysis of variance (one-way ANOVA) by Tukey test where treatment groups were compared with their respective controls. The regression analysis was carried out in Microsoft Excel 2003 between percent inhibition of mutagenicity and log values of concentrations of the plant extract.

3. Results

Murraya koenigii has been reported to contain a variety of phytochemicals of medicinal importance. In this study, we analyzed different fractions isolated based on the polarity of the aqueous and organic solvents and compared their relative antioxidant properties. The curry leaves were extracted separately in petrol ether, benzene, ethyl acetate, acetone, methanol and ethanol. Curry leaves yielded 1.0, 1.2, 1.2, 1.8, 2.2, and 0.8 percent of the extract when fractionated in petrol ether, benzene, ethyl acetate, acetone, methanol, and ethanol, respectively.

3.1. Antioxidant Activity of Curry

The total antioxidant activity of curry leaves fractions was tested by phosphomolybdenum method and compared with positive controls, ascorbic acid and BHT. All the tested fractions exhibited concentration-dependent antioxidant capacity with respect to ascorbic acid equivalents (Table 1). The benzene fraction showed maximum antioxidant capacity (3510.4 μmol) at 100 μg/mL followed by ethyl acetate (1982.3 μmol), petroleum ether (1967.2 μmol), and acetone (1783.1 μmol) fractions. However, methanol and ethanol fractions displayed relatively less antioxidant capacity (261–639 and 304–369, resp.) at the tested concentrations of 12.5–100 μg/mL.

Table 1: Antioxidant capacity of Murraya koenigii leaf fractions expressed as ascorbic acid equivalents (µmol/g of extract) by phosphomolybdenum method.

Concentration (µg/mL)
Antioxidant capacity (µmol/g of extract)

Petrol ether
Benzene
Ethyl acetate
Acetone
Methanol
Ethanol

12.5
980.0d  ±  18.3
1669.8d  ±  21.1
939.4d  ±  43.4
702.4d  ±  26.2
261.0d  ±  15.8
303.7d  ±  13.4

25
1531.6c  ±  50.7
2459.5c  ±  75.4
1399.2c  ±  19.5
1233.8c  ±  47.1
398.5c  ±  21.2
419.3c  ±  10.1

50
1663.0b  ±  56.9
3132.3b  ±  97.2
1589.2b  ±  66.9
1438.5b  ±  39.4
522.5b  ±  12.6
542.3b  ±  16.6

100
1967.2a  ±  67.4
3510.4a  ±  95.8
1982.3a  ±  84.3
1783.0a  ±  86.4
638.7a  ±  25.1
668.8a  ±  15.3

LSD at 5%
109.01
116.04
102.06
81.02
43.89
7.93

The above data are the mean of three experiments ± SD; different letters in columns show significant difference in means. LSD: least significance difference.

The free radical scavenging activity was measured as decolorizing activity following the trapping of the unpaired electron of DPPH as shown in Figure 1. The free radical scavenging activity of curry fractions by DPPH method exhibited a concentration-dependent response (Figure 1). The benzene fraction was found to be the most active free radical scavenger exhibited (88.3% decrease at a concentration of 100 μg/mL) followed by ethyl acetate (79.5%) and petrol ether (78.7%) fractions, while positive controls (ascorbic acid and BHT) at a concentration of 100 μg/mL inhibited 93.1% and 86.5% DPPH absorption, respectively. Acetone, methanol, and ethanol fractions showed decolorization of 66.1%, 50.7%, and 53.0%, respectively.

Figure 1: DPPH free radical scavenging activity of Murraya koenigii leaf fractions (petroleum ether, benzene, ethyl acetate, acetone, methanol, and ethanol) at different concentrations (12.5–100 μg/mL). The activity is compared with commercial antioxidants, ascorbic acid and BHT. Each data point represents the mean of three experiments. Standard deviation (≤4%) is not shown for clarity of the data.

The FRAP assay has been widely used in the evaluation of antioxidant component in dietary polyphenols. The reducing potential of the curry leaf fractions was concentration-dependent (Figure 2(a)). The benzene fraction demonstrated maximum reducing activity among the fractions. The activity was greater than the ascorbic acid and at par with BHT. The FRAP activity at 100 μg/mL concentration was in the order of BHT = benzene > ascorbic acid > petroleum ether > ethyl acetate > acetone > ethanol, and least in methanol fraction.

(a)

(b)

Figure 2: Reducing power of Murraya koenigii leaf fractions (petroleum ether, benzene, ethyl acetate, acetone, methanol, and ethanol). The extracts were tested in the range of 10–100 μg/mL concentrations in FRAP (a) and CUPRAC (b) assays and compared with ascorbic acid and BHT. Each data point represents the mean of three experiments. Standard deviation (≤4%) is not shown for clarity of the data.

Similarly, the antioxidant activity by CUPRAC assays indicated the highest reducing power potential in benzene fraction followed by petrol ether and ethyl acetate as shown in Figure 2(b). However, ascorbic acid had superior activity compared to benzene fraction. On the other hand, benzene fraction had more CUPRAC activity than BHT.

3.2. Antimutagenic Activity

There are several reports suggesting the correlation of antioxidants with high antimutagenic activity. In this study, benzene fraction demonstrating highest antioxidant activity was tested to explore antimutagenic potential of curry. The benzene fraction at concentrations of 12.5, 25, 50 and 100 μg/plate was found nonmutagenic as well as non-toxic to Salmonella typhimurium strains, either alone or in the presence of S9 mix. Doses of 1.5 μg/plate of sodium azide and 1 μg/plate of methyl methanesulfonate were chosen for the antimutagenicity study, since these doses were not toxic to the S. typhimurium tester strains. Similarly, BP and 2-AF were tested at the concentration of 1 and 5 μg/plate in the presence of S9 mix.

The antimutagenic activity of curry leaves was found to be dose dependent (Tables 2 to 5). At a dose of 100 μg/plate, antimutagenic response was significant ( ≤ 0.05) against TA97a with a decrease in the NaN₃-induced mutagenicity by 84.9% followed by TA100 (84.4%), TA98 (73.2%) and TA102 (72.2%) (Table 2). The linear regression analysis between extract dose and antimutagenic response against respective test mutagen showed strong correlation with respect to dose dependent response ranging from (0.95–1.0), respectively. Similarly, the decrease in number of His⁺ revertants was significant () for Salmonella typhimurium TA102 (86.0%) followed by TA100 (83.6%), TA97a (80.0%), and TA98 (74.1%) against MMS-induced mutagenicity as depicted in Table 3. Linear correlation between fraction dose and antimutagenic response was highly significant in all the strains ( = 0.96 or more).

Table 2: Effect of benzene fraction of Murraya koenigii on the mutagenicity induced by sodium azide (NaN₃) using Salmonella typhimurium strains.

Treatment

Dose (µg/plate)
Number of His⁺ revertants colonies/plate

TA97a
TA98
TA100
TA102

Spontaneous

140.0 ± 4.0
31.0 ± 3.6
128.7 ± 9.8
245.7 ± 23.3

Positive control (NaN₃)
1.5
246.3 ± 16.0
52.7 ± 2.1
352.0 ± 33.0
343.3 ± 33.3

Murraya koenigii
12.5
164.3 ± 12.3
46.0 ± 4.0
191.7 ± 13.3
286.7 ± 26.3

25
145.0 ± 15.5
37.3 ± 7.0
172.3 ± 18.9
260.0 ± 24.1

50
124.7 ± 9.1
30.7 ± 8.5
153.0 ± 19.7
245.3 ± 24.4

100
118.0 ± 10.5
24.0 ± 4.6
127.0 ± 15.5
228.3 ± 19.6

Murraya koenigii + NaN₃
12.5
225.3 ± 33.6 (25.6)
51.3 ± 6.0 (20.0)
316.3 ± 32.0 (22.3)
332.3 ± 34.9 (19.4)

25
200.7 ± 22.7* (45.1)
45.3 ± 4.2 (47.8)
258.0 ± 29.6* (52.3)
313.0 ± 32.1 (36.4)

50
168.0 ± 22.3** (64.4)
39.0 ± 8.2* (62.1)
212.7 ± 26.6** (70.0)
292.7 ± 18.6 (51.7)

100
137.3 ± 12.7*** (84.9)
31.7 ± 6.5** (73.2)
162.0 ± 21.0** (84.4)
260.3 ± 14.0* (72.2)

  value

18.069
8.288
33.690
6.917

  value

0.999
0.953
0.969
0.996

The data represented in the table is the mean ± SD values of three replicates. Mean values followed by asterisk are significantly different when compared to positive control at *P < 0.05, **P < 0.005, and ***P < 0.001. The values in parentheses are the inhibition rates of mutagenicity (%). Positive control: NaN₃, sodium azide. aNegative control; bpreincubation test; : linear regression analysis.

Table 3: Effect of benzene fraction of Murraya koenigii on the mutagenicity induced by methyl methanesulfonate (MMS) using Salmonella typhimurium strains.

Treatment

Dose (µg/plate)
Number of His⁺ revertants colonies/plate

TA97a
TA98
TA100
TA102

Spontaneous

140.0 ± 4.0
31.0 ± 3.6
128.7 ± 9.8
245.7 ± 23.3

Positive control (MMS)
1
443.7 ± 19.9
51.0 ± 2.7
952.7 ± 46.0
1195.3 ± 79.0

Murraya koenigii
12.5
164.3 ± 12.3
46.0 ± 4.0
191.7 ± 13.3
286.7 ± 26.3

25
145.0 ± 15.5
37.3 ± 7.0
172.3 ± 18.9
260.0 ± 24.1

50
124.7 ± 9.1
30.7 ± 8.5
153.0 ± 19.7
245.3 ± 24.4

100
118.0 ± 10.5
24.0 ± 4.6
127.0 ± 15.5
228.3 ± 19.6

  koenigii+ MMS

12.5
388.3 ± 31.2 (19.8)
50.3 ± 4.0 (13.4)
802.3 ± 57.1* (19.8)
862.3 ± 58.8** (36.6)

25
309.0 ± 30.8* (45.1)
45.0 ± 4.6 (43.9)
565.0 ± 45.1*** (49.7)
675.3 ± 56.9*** (55.6)

50
239.7 ± 20.2** (63.9)
38.3 ± 4.0* (62.3)
440.7 ± 48.6*** (64.0)
518.0 ± 32.1*** (71.3)

100
183.0 ± 17.5*** (80.0)
31.0 ± 5.6** (74.1)
262.3 ± 31.7*** (83.6)
363.7 ± 37.1*** (86.0)

  value treatment

81.635
9.877
225.881
178.255

  value

0.989
0.958
0.978
0.996

The data represented in the table is the mean ± SD values of three replicates. Mean values followed by asterisk are significantly different when compared to positive control at *P < 0.05; **P < 0.005 and ***P < 0.001. The values in parentheses are the inhibition rates of mutagenicity (%). Positive control: MMS: methyl methanesulfonate. aNegative control; bPre-incubation; : Linear regression analysis.

The antimutagenicity of M. koenigii benzene fraction has also been demonstrated against indirect acting mutagens benzo(a)pyrene (BP) and 2-aminoflourene (2-AF) that infers their mutagenicity by microsomal activation. At 100 μg/plate, the benzene fraction was found antimutagenic for BP-induced mutation at () as evident from the data presented in Table 4. The antimutagenic response was dose-dependent ( ≥ 0.98), and it ranged from 80.1% to 86.0%. Similarly, trend in antimutagenicity has been shown against 2-AF as presented in Table 5. Further, the linear regression analysis between extract dose and antimutagenic response showed strong correlation ranging from 0.99 to 1.0 against respective tester strains.

Table 4: Effect of benzene fraction of Murraya koenigii on the mutagenicity induced by benzo(a)pyrene with metabolic activation using Salmonella typhimurium strains.

Treatment
Dose (µg/plate)
Number of His⁺ revertants colonies/plate

TA97a
TA98
TA100
TA102

Spontaneous

143.7 ± 13.2
37.0 ± 3.0
135.3 ± 9.5
316.0 ± 14.5

Positive control (BP)
1
720.3 ± 28.5
155.0 ± 7.6
695.7 ± 17.0
648.0 ± 17.1

  koenigii
12.5
142.0 ± 18.3
50.3 ± 2.5
132.7 ± 16.0
265.0 ± 28.2

25
156.0 ± 14.4
42.7 ± 3.5
155.3 ± 17.2
296.3 ± 17.6

50
168.7 ± 21.7
35.0 ± 3.6

322.7 ± 31.1

100
181.3 ± 27.1
28.0 ± 3.6
175.3 ± 20.6
340.3 ± 31.3

  koenigii+ BP
12.5
592.3 ± 44.5* (22.1)
132.7 ± 19.2 (21.3)
540.0 ± 50.1** (27.7)
560.3 ± 31.2* (22.9)

25
501.7 ± 36.6** (38.7)
101.0 ± 19.3* (48.1)
435.3 ± 46.1*** (48.2)
501.7 ± 16.9*** (41.9)

50
382.7 ± 35.6*** (61.2)
(61.9)
352.3 ± 30.7*** (65.1)
436.0 ± 38.2*** (65.2)

100
276.0 ± 26.5*** (82.4)
(80.1)
253.7 ± 21.4*** (84.9)
382.0 ± 29.2*** (86.0)

  value treatment

168.149
49.036
149.651
67.488

  value

0.996
0.982
0.999
0.999

The data represented in the table is the mean ± SD values of three replicates. Mean values followed by asterisk are significantly different when compared to positive control at *P < 0.05; **P < 0.005 and ***P < 0.001. The values in parentheses are the inhibition rates of mutagenicity (%). Positive control: BP: benzo(a)pyrene.aNegative control; bPre-incubation test; : Linear regression analysis.

Table 5: Effect of benzene fraction of Murraya koenigii on the mutagenicity induced by 2-aminofluorene (2-AF) with metabolic activation using Salmonella typhimurium strains.

Treatment
Dose (µg/plate)
Number of His⁺ revertants colonies/plate

TA97a
TA98
TA100
TA102

Spontaneous

143.7 ± 13.2
37.0 ± 3.0
135.3 ± 9.5
316.0 ± 14.5

Positive control (2AF)
5
328.0 ± 12.0
262.3 ± 17.2
502.0 ± 19.1
1430.3 ± 32.5

Murraya koenigii
12.5
142.0 ± 18.3
50.3 ± 2.5
132.7 ± 16.0
265.0 ± 28.2

25
156.0 ± 14.4
42.7 ± 3.5
155.3 ± 17.2
296.3 ± 17.6

50
168.7 ± 21.7
35.0 ± 3.6

322.7 ± 31.1

100
181.3 ± 27.1
28.0 ± 3.6
175.3 ± 20.6
340.3 ± 31.3

Murraya koenigii+ 2-AF
12.5
276.3 ± 31.1 (27.8)
200.7 ± 17.0* (29.1)
422.3 ± 32.7* (21.6)
1185.3 ± 77.0** (21.0)

25
248.7 ± 28.0* (46.1)
161.0 ± 12.5** (46.1)
346.3 ± 21.6*** (44.9)
960.7 ± 70.8*** (41.4)

50
220.0 ± 25.0** (67.8)
114.7 ± 13.1*** (65.0)
280.7 ± 27.0*** (66.3)
655.0 ± 55.3*** (70.0)

100
202.3 ± 14.2*** (85.7)
70.0 ± 7.6*** (82.1)
205.0 ± 18.0*** (90.9)
462.0 ± 32.9*** (88.8)

value treatment

24.643
197.239
37.820
276.179

value

0.987
0.999
0.999
0.994

The data represented in the table is the mean ± SD values of three replicates. Mean values followed by asterisk are significantly different when compared to positive control at *P < 0.05; **P < 0.005 and ***P < 0.001. The values in parentheses are the inhibition rates of mutagenicity (%). Positive control: 2-AF, 2-aminoflourene.aNegative control; bPre-incubation test; : Linear regression analysis.

3.3. Phytochemical Analysis of Murraya koenigii (Leaf)

Phytochemical analysis of fractions revealed the presence of alkaloids, phenolics, and glycosides as major group of compounds (data not shown). The total phenolic content as gallic acid equivalent (mg/g) of Murraya koenigii fractions showed highest polyphenolic content () in benzene fraction followed by petrol ether (), ethyl acetate (), acetone (), ethanol (), and methanol () fractions.

Further, a total of 21 chemical components were identified in the benzene fraction of the leaf extract by GC-MS analysis (Supplementary –4; Table S1 in Supplementary Material found online at http://dx.doi.org/10.1155/2013/263509). These numbers may be extended with the help of chemo metric techniques. The major compounds identified were caryophyllene (14.8%) followed by 3-undecen-5-yne (Z)-(9.52%), phytol (9.17%), 2-methyl-3H-phenanthro[3,4-D] imida (8.90%), caryophyllene oxide (6.61%), propylparaben (6.11%), D-limonene (6.01%). The remaining compounds were present in percentages of (1.06–5.72) as depicted in Table 6.

Table 6: Components of Murraya koenigii benzene fraction as identified by GC-MS analysis.

Peak no.
Components
Retention time
Area (%)

Caryophyllene
11.19
14.8

-Caryophyllene
11.77
2.79

1H-Cyclopropa[a] naphthalene, 1a,2,
12.37
2.93

Caryophyllene oxide
13.24
6.61

Spiro[4.4]nonan-2-one
13.60
2.49

10,10-Dimethyl-2,6-dimethylenebicy
13.93
3.32

D-Limonene
14.10
6.01

Propylparaben
15.80
6.11

Salicylamide
16.00
1.42

9-Borabicyclo[3.3.1]nonane, 9-hydr
18.55
5.72

1,2-Diphenylethanethione
18.69
0.54

Phytol
18.91
9.17

11,14-Eicosadienoic acid, methyl e
19.44
2.59

3-Undecen-5-yne, (Z)-
19.58
9.52

Phenol, 2-methoxy-4-[2-(4-hydroxyphenyl)]
20.71
1.94

2,6-Octadien-1-ol, 3,7-dimethyl-,
22.41
1.06

Docosane, 11-butyl-
23.95
5.30

2-Methyl-3H-phenanthro[3,4-D] imida
24.02
8.90

Propanenitrile
24.52
2.21

Pentatriacontane
25.82
4.22

Vitamin A aldehyde
26.57
2.33

4. Discussion

Antioxidants play an important role in biological systems by suppressing the formation of active oxygen species by reducing hydroperoxides (ROO•) and H₂O₂ and scavenging free radicals among others. Over the past few decades, scientific research has indicated a credible basis for some of the traditional ethnomedicinal uses of spices. Therefore, we have focused our study to elucidate the broad-spectrum antioxidant potential of M. koenigii leaf fractions by means of four different in vitro tests including total antioxidant capacity by molybdenum method, free radicals scavenging by DPPH, and reducing power by FRAP and CUPRAC assays. The method to detect total antioxidant activity is based on the reduction of Mo (VI) to Mo (V) by the antioxidant compounds with the formation of a green Mo (V) complex which shows maximum absorption at ~700 nm [27]. Whereas other two methods are based on scavenging of free radicals (DPPH) and reduction of Fe[(CN)₆]₃ to Fe[(CN)₆]₂ in FRAP assay and Cu²⁺ to Cu¹⁺ in CUPRAC assay.

This study demonstrated that the sequential fractionation of curry leaves in various solvents resulted in the extraction of antioxidant bioactive compounds mainly in benzene, petrol ether, acetone, methanol and ethanol fractions. The benzene fraction of M. koenigii was found to contain the highest total phenolics and to be the most active fraction in all in vitro antioxidant assays tested. Other fractions showed activity in order of petrol ether > ethyl acetate > acetone > methanol > ethanol. Polyphenols have been reported to have many beneficial health effects including antioxidant activity. In this study, the total phenolic content was the highest in benzene fraction followed by other suggesting the correlation between antioxidant and polyphenolics content. A series of papers have shown similar correlation including few from this lab [12, 17, 18].

M. koenigii leaves were found to have the highest antioxidant activities and total phenolic content in methanol extracts as studied in [28]. These differences might be due to the extraction of curry leaves in methanol only instead of fractionating them into different solvents. Our findings highlight that M. koenigii benzene fraction is the potential source of antioxidants. It is probably the first report on the sequential fraction of M. koenigii leaves in respective solvents for the evaluation of antioxidant activities. However, other fractions might be having different levels and composition of antioxidant compounds which needs further phytochemical characterization.

Moreover, our results also indicated terpenes as the major components in benzene fraction as identified by GC-MS analysis. It is evident that the antioxidant activities of M. koenigii may be related to various carbazole alkaloids and/or phenolic compounds including monoterpenes [29, 30]. Comparative studies of the major components have also indicated terpenes as the most versatile components in M. koenigii leaves [29], while many carbazole alkaloids have been isolated and identified from different parts of the plant [31, 32]. Besides these phytochemicals, the curry leaves are also a rich source of nutrients including vitamin A and vitamin C [33].

On the basis of antioxidant potential, the most active fraction (benzene) was tested for its antimutagenic potential against S. typhimurium tester strains. Interestingly, a significant antimutagenicity () against direct and indirect acting mutagens in the presence of S9 was recorded. Since BP, a known carcinogenic agent, cannot be metabolized by Salmonella to an appreciable extent, so a metabolizing system of supernatant of liver homogenate from Aroclor induced rats (S9) is included in the assay. A number of reactive intermediates like BP-4,5-oxide and 9-hydroxy-BP-4,5-oxide are formed by BP with this activating system that helps in the binding of BP to bacterial DNA [34]. Similarly, the antimutagenic activity against 2-AF-induced mutagenicity was tested in the presence of S9 fraction.

In our study, none of the tested extracts exhibited any mutagenic effect in the Ames test in the absence of enzymatic metabolism. This suggests that DNA does not seem to be a relevant target for the extract tested, and it did not produce DNA lesions that block DNA synthesis, leading to the induction of the SOS system [35]. It is evident from the results of the present study that the antimutagenic behavior of M. koenigii is probably due to its antioxidant activities which may be related to various phenolics, monoterpenes and carbazole alkaloids, and so forth [29, 30].

The GC-MS analysis and total phenolic content revealed terpenes as the major active constituents in the tested fraction. The studies on antimutagenic activity of plants have indicated the involvement of chemical constituents which could act as nonspecific redox agents, free radical scavengers, or ligands for binding metals or toxic principles [36]. Besides these, the curry leaves contained carotenoids and retinoids, preformed types of vitamin A, which have been clearly associated with prevention of the induction of cancer and inhibition spontaneous and induced cancers [37]. Recently, terpenes are also reported to have antimutagenic effects in bacterial reverse mutation assay [38] as well as against UV- 4NQO- and t-BOOH induced mutagenesis in E. coli K12 and E. coli WP2 by reversion assays [39]. Therefore, our study highlights that the benzene fraction of the curry leaf has broad-spectrum antimutagenic properties. Further studies are needed in order to isolate and characterize the active constituents present in it for their therapeutic efficacy.

In summary, we have shown for the first time that curry leaf, yielding highest phenolics in benzene fractions upon sequential fractionation, is a promising source of antioxidant compounds that may be responsible for its antimutagenic properties. Further studies are needed to isolate the active principles, as well as to elucidate the role of various interacting phytocompounds in influencing therapeutic potential and efficacy in vivo.

Conflict of Interests

The authors declare that there is no conflict of interests.

Acknowledgments

The authors are thankful to the UGC, New Delhi, for financial assistance in the form of Research Fellowship to Maryam Zahin through AMU, Aligarh. They are also grateful to the Director, SAIF, IIT Bombay, India, for the cooperation in chemical spectral analysis.

References

Y. Gilgun-Sherki, E. Melamed, and D. Offen, “Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier,” Neuropharmacology, vol. 40, no. 8, pp. 959–975, 2001.

D. Krishnaiah, R. Sarbatly, and R. Nithyanandam, “A review of the antioxidant potential of medicinal plant species,” Food and Bioproducts Processing, vol. 89, no. 3, pp. 217–233, 2011.

K. H. Cheeseman and T. F. Slater, “An introduction to free radical biochemistry,” British Medical Bulletin, vol. 49, no. 3, pp. 481–493, 1993.

R. A. Larson, “The antioxidants of higher plants,” Phytochemistry, vol. 27, no. 4, pp. 969–978, 1988.

A. Mitrović and J. Bogdanović, “Effect of gibberellic acid on total antioxidant activity during chenopodium rubrum l. Ontogenesis in vitro,” Archives of Biological Sciences, vol. 61, no. 1, pp. 49–55, 2009.

K. Yoshikawa, K. Inagaki, T. Terashita, J. Shishiyama, S. Kuo, and D. M. Shankel, “Antimutagenic activity of extracts from Japanese eggplant,” Mutation Research—Genetic Toxicology, vol. 371, no. 1-2, pp. 65–71, 1996.

N. S. Sangwan, S. Shanker, R. S. Sangwan, and S. Kumar, “Plant-derived products as antimutagens,” Phytotherapy Research, vol. 12, no. 6, pp. 389–399, 1998.

W. M. El-Sayed and W. A. Hussin, “Antimutagenic and antioxidant activity of novel 4-substituted phenyl-2, 2′-bichalcophenes and aza-analogs,” Journal of Drug Design, Development and Therapy, vol. 7, pp. 73–81, 2013.

A. Cardador-Martínez, A. Albores, M. Bah et al., “Relationship among antimutagenic, antioxidant and enzymatic activities of methanolic extract from common beans (Phaseolus vulgaris L),” Plant Foods for Human Nutrition, vol. 61, no. 4, pp. 161–168, 2006.

J. Musarrat, F. Aqil, and I. Ahmad, “Mutagenicity and antimutagenicity of medicinal plants,” in Modern Phytomedicine: Turning Medicinal Plants into Drug, I. Ahmad, F. Aqil, and M. Owais, Eds., pp. 271–286, Wiley-VCH, Weinheim, Germany, 2006.

S. Bala and I. S. Grover, “Antimutagenicity of some citrus fruits in Salmonella typhimurium,” Mutation Research, vol. 222, no. 3, pp. 141–148, 1989.

F. Aqil, M. Zahin, and I. Ahmad, “Antimutagenic activity of methanolic extracts of four ayurvedic medicinal plants,” Indian Journal of Experimental Biology, vol. 46, no. 9, pp. 668–672, 2008.

K. Kaur, S. Arora, S. Kumar, and A. Nagpal, “Antimutagenic activities of acetone and methanol fractions of Terminalia arjuna,” Food and Chemical Toxicology, vol. 40, no. 10, pp. 1475–1482, 2002.

S. M. Hiremath, B. B. Madalageri, and P. W. Basarkar, “Composition of curry leaf (Murraya koenigii Spreng) oil during leaf growth,” Indian Perfumer, vol. 42, no. 2, pp. 58–59, 1998.

J. Mishra, A. Yousuf, R. D. Singh, and A. Aradhana, “Phytochemical investigation and in-vitro antioxidant potential of leaves of Murraya koenigii,” International Journal of Integrative Biology, vol. 7, no. 3, pp. 171–174, 2009.

S. D. Bonde, L. S. Nemade, M. R. Patel, and A. A. Patel, “Murraya koenigii (Curry leaf): ethnobotany, phytochemistry and pharmacology—a review,” International Journal of Pharmaceutical and Phytopharmacological Research, vol. 1, pp. 23–27, 2011.

M. Zahin, I. Ahmad, and F. Aqil, “Antioxidant and antimutagenic activity of Carum copticum fruit extracts,” Toxicology in Vitro, vol. 24, no. 4, pp. 1243–1249, 2010.

M. Zahin, F. Aqil, and I. Ahmad, “Broad spectrum antimutagenic activity of antioxidant active fraction of Punica granatum L. peel extracts,” Mutation Research—Genetic Toxicology and Environmental Mutagenesis, vol. 703, no. 2, pp. 99–107, 2010.

P. Prieto, M. Pineda, and M. Aguilar, “Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of vitamin E,” Analytical Biochemistry, vol. 269, no. 2, pp. 337–341, 1999.

M. A. Gyamfi, M. Yonamine, and Y. Aniya, “Free-radical scavenging action of medicinal herbs from Ghana: Thonningia sanguinea on experimentally-induced liver injuries,” General Pharmacology, vol. 32, no. 6, pp. 661–667, 1999.

M. Oyaizu, “Studies on products of browning reactions: antioxidant activities of products of browning reaction prepared from glucosamine,” Japaneese Journal of Nutrition, vol. 44, pp. 307–315, 1986.

F. Aqil, R. Munagala, M. V. Vadhanam et al., “Anti-proliferative activity and protection against oxidative DNA damage by punicalagin isolated from pomegranate husk,” Food Research International, vol. 49, no. 1, pp. 345–353, 2012.

R. Apak, K. Güçlü, B. Demirata et al., “Comparative evaluation of various total antioxidant capacity assays applied to phenolic compounds with the CUPRAC assay,” Molecules, vol. 12, no. 7, pp. 1496–1547, 2007.

I. Gülçin, “Antioxidant activity of l-adrenaline: a structure-activity insight,” Chemico-Biological Interactions, vol. 179, no. 2-3, pp. 71–80, 2009.

D. M. Maron and B. N. Ames, “Revised methods for the Salmonella mutagenicity test,” Mutation Research, vol. 113, no. 3-4, pp. 173–215, 1983.

G. A. Spanos and R. E. Wrolstad, “Influence of processing and storage on the phenolic composition of thompson seedless grape juice,” Journal of Agricultural and Food Chemistry, vol. 38, no. 7, pp. 1565–1571, 1990.

P. S. Negi, G. K. Jayaprakasha, and B. S. Jena, “Antioxidant and antimutagenic activities of pomegranate peel extracts,” Food Chemistry, vol. 80, no. 3, pp. 393–397, 2003.

S. Gupta and J. Prakash, “Studies on Indian green leafy vegetables for their antioxidant activity,” Plant Foods for Human Nutrition, vol. 64, no. 1, pp. 39–45, 2009.

V. S. Rana, J. P. Juyal, R. Rashmi, and M. A. Blazquez, “Chemical constituents of the volatile oil of Murraya koenigii leaves,” International Journal of Aromatherapy, vol. 14, no. 1, pp. 23–25, 2004.

L. J. M. Rao, K. Ramalakshmi, B. B. Borse, and B. Raghavan, “Antioxidant and radical-scavenging carbazole alkaloids from the oleoresin of curry leaf (Murraya koenigii Spreng.),” Food Chemistry, vol. 100, no. 2, pp. 742–747, 2007.

Y. Tachibana, H. Kikuzaki, N. H. Lajis, and N. Nakatani, “Antioxidative activity of carbazoles from Murraya koenigii leaves,” Journal of Agricultural and Food Chemistry, vol. 49, no. 11, pp. 5589–5594, 2001.

R. S. Ramsewak, M. G. Nair, G. M. Strasburg, D. L. DeWitt, and J. L. Nitiss, “Biologically active carbazole alkaloids from Murraya koenigii,” Journal of Agricultural and Food Chemistry, vol. 47, no. 2, pp. 444–447, 1999.

P. R. Bhandari, “Curry leaf (Murraya koenigii) or cure leaf: review of its curative properties,” Journal of Medical Nutrition and Nutraceuticals, vol. 1, pp. 92–97, 2012.

M. Osborne and N. Crosby, Metabolism Benzopyrenes, Cambridge University Press, New York, NY, USA, 1987.

J. M. Arif, M. Kunhi, Y. M. Siddiqui et al., “Differential modulation of benzo[a]pyrene-derived DNA adducts in MCF-7 cells by marine compounds,” International Journal of Cancer Prevention, vol. 1, pp. 259–268, 2004.

D. Sarkar, A. Sharma, and G. Talukder, “Plant extracts as modulators of genotoxic effects,” Botanical Review, vol. 62, no. 4, pp. 275–300, 1996.

J. S. Bertram and A. L. Vine, “Cancer prevention by retinoids and carotenoids: independent action on a common target,” Biochimica et Biophysica Acta, vol. 1740, no. 2, pp. 170–178, 2005.

A. di Sotto, M. G. Evandri, and G. Mazzanti, “Antimutagenic and mutagenic activities of some terpenes in the bacterial reverse mutation assay,” Mutation Research—Genetic Toxicology and Environmental Mutagenesis, vol. 653, no. 1-2, pp. 130–133, 2008.

B. Nikolic, J. Stanojevic, D. Mitic, B. Vukovic-Gacic, J. Knezevic-Vukcevic, and D. Simic, “Comparative study of the antimutagenic potential of Vitamin E in different E. coli strains,” Mutation Research, vol. 564, no. 1, pp. 31–38, 2004.